Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sentinel node biopsy in breast cancer].

Shigeru Imoto1, Noriaki Wada, Takahiro Hasebe

  • 1Breast Surgery Division, National Cancer Center Hospital East.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|July 31, 2002
PubMed
Summary

Sentinel node biopsy offers a less invasive approach for breast cancer patients with negative nodes, potentially avoiding axillary lymph node dissection. Ongoing trials and unresolved issues in Japan highlight the need for further research on this technique.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline peripheral blood immune markers associated with clinical outcomes in patients with advanced breast cancer treated with trastuzumab deruxtecan.

BMC cancer·2026
Same author

Baseline Neutrophil-to-Lymphocyte Ratio Predicts Overall Survival in PD-L1-positive Advanced Triple-negative Breast Cancer With Immune-checkpoint-inhibitor Treatment.

Cancer diagnosis & prognosis·2026
Same author

Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report.

Molecular and clinical oncology·2026
Same author

Survey of the Senologic International Society (SIS) on the Use of Preoperative Breast MRI in Early-Stage Breast Cancer: A Global Perspective on Current Practice.

European journal of breast health·2026
Same author

Optimizing axillary surgery for patients with clinically node-negative and node-positive breast cancer.

Surgery today·2026
Same author

Compartment-Specific CD138 Expression Defines an Aggressive Breast Cancer Phenotype with Distinct Transcriptomic Features.

Cancers·2026

Area of Science:

  • Oncology
  • Surgical Pathology
  • Minimally Invasive Surgery

Context:

  • Sentinel node biopsy (SNB) is an alternative to axillary lymph node dissection (ALND) for breast cancer.
  • Western countries are conducting phase III trials comparing SNB with ALND.
  • Observational studies are evaluating SNB in cases with histologically negative sentinel nodes.

Purpose:

  • To discuss the current status and unresolved issues of sentinel node biopsy in breast cancer treatment in Japan.
  • To address challenges including optimal procedures, pathologic evaluation, radiation exposure, insurance, and patient selection for SNB.

Summary:

  • Sentinel node biopsy is a promising technique to reduce unnecessary axillary lymph node dissection in breast cancer.
  • While trials are ongoing in Western countries, Japan faces several unresolved issues regarding SNB implementation.

Related Experiment Videos

  • Key areas of concern include procedural optimization, pathologic assessment, radiation safety, insurance coverage, and defining SNB indications.

    • Impact:

    • SNB has the potential to significantly improve patient outcomes and reduce surgical morbidity in breast cancer care.
    • Addressing the current challenges in Japan is crucial for the widespread and safe adoption of SNB.
    • Further research and standardization are needed to optimize SNB protocols and ensure equitable access to this minimally invasive procedure.